Invivoscribe® is a comprehensive CDx partner, providing ISO13485 compliant biomarker development, cGMP manufacturing, regulatory capability, clinical trial services, and global commercialization. We are ISO13485 compliant and offer internationally standardized testing through our ISO15189 laboratory network (US, Europe, Asia). Our offerings include NGS gene and MRD panels, FLT3 and NPM1 mutation assays, B- and T-cell clonality and MRD assays - all with design-controlled bioinformatics software.